Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 2, March-April, p. 351–357

doi: 10.17219/acem/61429

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Antiarrhythmic properties of atrial pacing

Magdalena Kliś1,A,B,C,D,E,F, Agnieszka Sławuta2,A,B,C,D,E,F, Jacek Gajek3,A,B,C,D,E,F

1 Department of Cardiology, Province Specialist Hospital, Wrocław, Poland

2 Department of Cardiology, Klodzko County Hospital, Poland

3 Department of Clinical Nursing, Wroclaw Medical University, Poland

Abstract

Bradycardia, atrial stretch and dilatation, autonomic nervous system disorders, and the presence of triggers such as atrial premature contractions, are factors which predispose a person to paroxysmal AF. Atrial pacing not only eliminates bradycardia but also prevents atrial premature contractions and dispersion of refractoriness, which are a substrate for atrial fibrillation. As the prolonged duration of atrial activation during pacing, especially from locations changing the physiological pattern of this activation (right atrium lateral wall, right atrium appendage), negatively influences both a mechanical and an electrical function of the atria, the atrial pacing site affects an atrial arrhythmogenesis. A conventional atrial lead location in the right atrium appendage causes non-physiological activation propagation, resulting in a prolongation of the activation time of both atria. This location is optimal according to a passive fixation of the atrial lead but the available contemporary active fixation leads could potentially be located in any area of the atrium. There is growing evidence of the benefit of pacing, imitating the physiological propagation of impulses within the atria. It seems that the Bachmann’s bundle pacing is the best pacing site within the atria, not only positively influencing the atrial mechanical function but also best fulfilling the so-called atrial resynchronization function, in particular in patients with interatrial conduction delay. It can be effectively achieved using only one atrial electrode, and the slight shortening of atrioventricular conduction provides an additional benefit of this atrial pacing site.

Key words

atrial pacing, alternative sites, atrial fibrillation, Bachmann’s bundle

References (44)

  1. Roithinger FX, Cheng J, Sippens-Groenewegen A, et al. Use of electroanatomic mapping to delineate transseptal atrial conduction in hu-mans. Circulation. 1999;100:1791–1797.
  2. Lemery R, Soucie L, Martin B, Tang AS, Green M, Healey J. Human study of biatrial electrical coupling: Determinants of endocardial septal activation and conduction over interatrial connections. Circulation. 2004;110:2083–2089.
  3. Betts TR, Roberts PR, Morgan JM. High-density mapping of left atrial endocardial activation during sinus rhythm and coronary sinus pacing in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15:1111–1117.
  4. O’Neal WT, Almahmoud MF, Soliman EZ. Resting heart rate and incident atrial fibrillation in the elderly. Pacing Clin Electrophysiol. 2015;38:591–597.
  5. Uhm JS, Mun HS, Wi J, et al. Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation. Pacing Clin Electrophysiol. 2013;36:163–171.
  6. Hoffmann E, Sulke N, Edvardsson N, et al. Atrial fibrillation therapy trial investigators. New insights into the initiation of atrial fibrillation: A detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker fea-tures. Circulation. 2006;113:1933–1941.
  7. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350:1210–1216.
  8. Kerr CR, Connolly SJ, Abdollah H, et al. Canadian trial of physiological pacing: Effects of physiological pacing during long-term follow-up. Circulation. 2004;109:357–362.
  9. Hjortshøj S, Riahi S, Nielsen JC, Skjøth F, Lundbye-Christensen S, Andersen HR. DANPACE Investigators. Does atrial pacing lead to atrial fibril-lation in patients with sick sinus syndrome? Insights from the DANPACE trial. Europace. 2014;16:241–245.
  10. Elkayam LU, Koehler JL, Sheldon TJ, Glotzer TV, Rosenthal LS, Lamas GA. The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: A meta-analysis. Pacing Clin Electrophysiol. 2011;34:1593–1599.
  11. Inoue N, Ishikawa T, Sumita S, et al. Suppression of atrial fibrillation by atrial pacing. Circ J. 2006;70:1398–1401.
  12. Nielsen JC, Thomsen PE, Højberg S, et al. DANPACE Investigators. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J. 2011; 32:686–696.
  13. Kuniewicz M, Rydlewska A, Karkowski G, Lelakowska-Pieła M, Majewski J, Lelakowski J. Effectiveness of atrial versus atrioventricular pacing for sick sinus syndrome during long-term follow-up. Kardiol Pol. 2015;73:7–16.
  14. Nielsen JC, Thomsen PE, Højberg S, et al. DANPACE investigators. Atrial fibrillation in patients with sick sinus syndrome: The association with PQ-interval and percentage of ventricular pacing. Europace. 2012;14:682–689.
  15. Veasey RA, Arya A, Freemantle N, et al. The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: The “MinVPace” study. J Interv Card Electrophysiol. 2010;28: 51–57.
  16. Bennett D. Comparison of the acute effects of pacing the atrial septum, right atrial appendage, coronary sinus os, and the latter two sites simultaneously on the duration of atrial activation. Heart. 2000;84:193–196.
  17. Katsivas A, Manolis AG, Lazaris E, Vassilopoulos C, Louvros N. Atrial septal pacing to synchronize atrial depolarization in patients with delayed interatrial conduction. Pacing Clin Electrophysiol. 1998;21: 2220–2225.
  18. Healey JS, Israel CW, Connolly SJ, et al. Relevance of electrical remodeling in human atrial fibrillation: Results of the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial mechanisms of atrial fibrilla-tion study. Circ Arrhythm Electrophysiol. 2012;5:626–631.
  19. Kristensen L, Nielsen JC, Mortensen PT, et al. Sinus and paced P wave duration and dispersion as predictors of atrial fibrillation after pace-maker implantation inpatients with isolated sick sinus syndrome. Pace. 2004;27:606–614.
  20. De Sisti A, Leclercq JF, Stiubei M, Fiorello P, Halimi F, Attuel P. P Wave duration and morphology predict atrial fibrillation recurrence in patients with sinus node dysfunction and atrial-based pacemaker. PACE. 2002;25,1546–1554.
  21. Bayés de Luna A, Cladellas M, Oter R, et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supra-ventricular tachyarrhythmia. Eur Heart J. 1988;9:1112–1118.
  22. Endoh Y, Nakamura A, Suzuki T, et al. Clinical significance of prolonged P wave width after right atrial appendage pacing In sick sinus syn-drome. Circ J. 2003;67:485–489.
  23. Stabile G, Senatore G, De Simone A, et al. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol. 1999;10:2–9.
  24. de Voogt WG, van Mechelen R, van den Bos A, Scheffer M, van Hemmel NM, Levine PA. Electrical characteristics of low atrial septum pacing compared with right atrial appendage pacing. Europace. 2005;7:60–66.
  25. Minamiguchi H, Nanto S, Onishi T, Watanabe T, Uematsu M, Komuro I. Low atrial septal pacing with dual-chamber pacemakers reduces atrial fibrillation in sick sinus syndrome. J Cardiol. 2011;57:223–230.
  26. Hakacova N, Velimirovic D, Margitfalvi P, Hatala R, Buckingham TA. Septal atrial pacing for the prevention of atrial fibrillation. Europace. 2007;9;1124–1128.
  27. Wang M, Siu CW, Lee KL, et al. Effects of right low atrial septal vs right atrial appendage pacing on atrial mechanical function and dyssyn-chrony in patients with sinus node dysfunction and paroxysmal atrial fibrillation. Europace. 2011;13(9:1268–1274.
  28. Savitt MA, Rankin JS. Use of Bachmann’s bundle for bipolar atrial pacing. Ann Thorac Surg. 1993;56:183–184.
  29. Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: Results of a multicenter randomized trial. J Cardiovasc Electrophysiol. 2001;12:912–917.
  30. Bailin S. Is Bachmann’s bundle the only site for single-site pacing to prevent atrial fibrillation? Results of multicenter randomized trial. Card Electrophysiol Rev. 2003;7:325–328.
  31. Sławuta A, Skoczyński P, Kliś M, et al. Bachmann’s bundle pacing improves left ventricle filling and reduces the need for ventricular pacing. Eur Heart J. 2014;35:90(Abstract suppl).
  32. Sławuta A, Skoczyński P, Bańkowski T, Kliś M, Gajek J. Bachmann’s bundle pacing not only improves interatrial conduction but also reduces the need for ventricular pacing. Eur Heart J. 2013;34:489(Abstract suppl).
  33. Spitzer S, Wacker P, Gazarek S, Malinowski K, Schibgilla V. Primary prevention of atrial fibrillation: Does the atrial lead position influence the incidence of atrial arrhythmias in patients with sinus node dysfunction? Results from PASTA study. PACE. 2009;32:1553–1561.
  34. Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhyth-mic drug therapy. J Am Coll Cardiol. 2002;40:1140–1150.
  35. Prakash A, Saksena S, Ziegler PD, et al. Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: Further observations from the dual site atrial pacing for prevention of atrial fibrillation trial. J Interv Card Electrophysiol. 2005;12:177–187.
  36. Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol. 1998;32:1900–1908.
  37. Tse HF, Hettrick DA, Mehra R, Lau CP. Improved atrial mechanical efficiency during alternate- and multiple-site atrial pacing compared with conventional right atrial appendage pacing: implications for selective site pacing to prevent atrial fibrillation. J Am Coll Cardiol. 2006;47:209–212.
  38. D’Allonnes GR, Pavin D, Leclercq C, et al. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: A nine-year experience. J Cardiovasc Electrophysiol. 2000;11:1081–1091.
  39. Lau CP, Tse HF, Yu CM, et al. New indication for preventive pacing in atrial fibrillation (NIPP-AF) investigators. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. J Am Cardiol. 2001;88:371–375.
  40. Yu WC, Chen SA, Tai CT, Feng AN, Chang MS. Effects of different atrial pacing modes on atrial electrophysiology: Implicating the mechanism of biatrial pacing in prevention of atrial fibrillation. Circulation. 1997;96:2992–2996.
  41. Hansen JC, Latchamsetty R, Lavi N, et al. High-density biatrial pacing protects against atrial fibrillation by synchronizing left atrial tissue. J Interv Card Electrophysiol. 2010;27:81–87.
  42. Levy T, Walker S, Rochelle J, Paul V. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am J Cardiol. 1999;84:426–429.
  43. Lewicka-Nowak E, Kutarski A, Dabrowska-Kugacka A, Rucinski P, Zagozdzon P, Raczak G. A novel method of multisite atrial pacing, incorpo-rating Bachmann’s bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation. Europace. 2007;9:805–811.
  44. Lewicka-Nowak E, Dabrowska-Kugacka A, Rucinski P, Kozlowski D, Raczak G, Kutarski A. Atrial function during different multisite atrial pacing modalities in patients with bradycardia–tachycardia syndrome. Circ J. 2009;73:2029–2035.
© Wroclaw Medical University